Cross talks between the immune and lymphatic endothelial cells regulate inflammatory lymph node lymphangiogenesis: defining a new therapeutic approach

Sonia Elhadad

doi:10.1186/2051-1426-1-s1-p184

Sonia Elhadad

Open Access

https://doi.org/10.1186/2051-1426-1-s1-p184

Copy DOI

Abstract

Meeting abstracts The lymphatic system serves as the primary route for the metastasis of many cancers and the extent of lymphangiogenesis involvement is the most important indicator of tumor aggressiveness. Despite the apparent importance of the lymphatic vessels for tumor dissemination, it has

Highlights

The lymphatic system serves as the primary route for the metastasis of many cancers and the extent of lymphangiogenesis involvement is the most important indicator of tumor aggressiveness
Our data suggest that lymphangiogenesis can be targeted therapeutically at different stages, and by different way
Inflammatory lymph node lymphangiogenesis is a multi step process defined by initiation, expansion and a return to quiescence

Summary

Introduction

The lymphatic system serves as the primary route for the metastasis of many cancers and the extent of lymphangiogenesis involvement is the most important indicator of tumor aggressiveness. Elhadad Journal for ImmunoTherapy of Cancer 2013, 1(Suppl 1):P184 http://www.immunotherapyofcancer.org/content/1/S1/P184 Cross talks between the immune and lymphatic endothelial cells regulate inflammatory lymph node lymphangiogenesis: defining a new therapeutic approach From Society for Immunotherapy of Cancer 28th Annual Meeting National Harbor, MD, USA.

Results

Conclusion